JW Lifescience Corporation (KRX:234080)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,600
+130 (1.04%)
At close: Oct 2, 2025

Revenue by Product

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202014 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2014 - 2019
Intravenous Fluids
222.48B
Log In
Log In
Log In
Log In
Upgrade
Intravenous Fluids Growth
7.55%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202014 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2014 - 2019
South Korea
222.48B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
7.55%
Log In
Log In
Log In
Log In
Upgrade